Raptor Pharmaceuticals
Engages in the discovery, research, and preclinical development of drug candidates and drug-targeting platforms for the treatment of various brain disorders and neurodegenerative diseases, genetic disorders, and cancer through the proprietary use of .
HQ location
Novato, United States
Website
Launch date
Enterprise value
$60—90m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
$800m | Acquisition | ||
| Total Funding | 000k | ||
Lincoln Park Capital Fund(exited)
Iroquois Capital(exited)
Heights Capital Management(exited)
Deerfield Capital Management(exited)
Dafna Capital Management(exited)
HealthCare Royalty(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads